Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Now Available: Birch Pollen Allergy - Pipeline Review, H1 2013


Print article Print article
2013-06-15 12:53:18 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Birch Pollen Allergy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy. Birch Pollen Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Birch Pollen Allergy.
* A review of the Birch Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Birch Pollen Allergy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/618622_birch_pollen_allergy_pipeline_review_ ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Birch Pollen Allergy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Birch Pollen Allergy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Birch Pollen Allergy Overview
Therapeutics Development
An Overview of Pipeline Products for Birch Pollen Allergy
Birch Pollen Allergy Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Birch Pollen Allergy Therapeutics - Products under Development by Companies
Companies Involved in Birch Pollen Allergy Therapeutics Development
ALK-Abello A/S
Allergopharma Joachim Ganzer KG
Circassia Holdings Ltd.
ANERGIS SA
Biomay AG
Birch Pollen Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Birch Pollen Allergoid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL-0206st - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALK Birch Pollen Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Birch Pollen Allergen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BM-31 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ToleroMune Birch Allergy T-Cell Vaccines - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AllerT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL-102 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Birch Pollen Allergy Therapeutics - Drug Profile Updates
Birch Pollen Allergy Therapeutics - Discontinued Products
Birch Pollen Allergy Therapeutics - Dormant Products
Birch Pollen Allergy - Product Development Milestones
Featured News & Press Releases
Nov 08, 2012: Long-Term Immunomodulation Induced By Anergis's COP Allergy Vaccine AllerT Extends To Fourth Year After Treatment
Nov 06, 2012: Anergis Starts European Phase IIb Clinical Trial With AllerT In Patients With Allergy To Birch Pollen
Aug 31, 2010: Anergis's Ultra-Fast Treatment Against Birch Pollen Allergy Demonstrates Long Term Immunoregulatory Effect
Jul 17, 2009: Anergis Reports Encouraging Seasonal Clinical Results With Birch Pollen Allergy Drug Candidate AllerT
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Birch Pollen Allergy, H1 2013
Products under Development for Birch Pollen Allergy - Comparative Analysis, H1 2013
Number of Products under Development by Companies, H1 2013
Comparative Analysis by Late Stage Development, H1 2013
Comparative Analysis by Mid Clinical Stage Development, H1 2013
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013
Products under Development by Companies, H1 2013
ALK-Abello A/S, H1 2013
Allergopharma Joachim Ganzer KG, H1 2013
Circassia Holdings Ltd., H1 2013
ANERGIS SA, H1 2013
Biomay AG, H1 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=618622&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com